BioNTech Results Presentation Deck slide image

BioNTech Results Presentation Deck

Infectious Diseases: A Long-term Growth Pillar mRNA vaccines to combat major global health burden Malaria ¹: Development of first mRNA-based Malaria vaccine recently started Implementation of sustainable end-to-end vaccine supply solutions in Africa planned HIV and tuberculosis ²: Preclinical development of multiple product candidates ongoing Opportunity to impact infectious diseases with high unmet need Up to 10 mRNA vaccine candidates in preclinical development³ 9 1 Collaboration with KENUP Foundation; 2Collaboration with Bill & Melinda Gates Foundation; University of Pennsylvania collaboration BNT161 influenza vaccine candidate designed to improve traditional vaccines • FIH trial expected Q3 2021 Eligible for milestone payments and royalties through Pfizer agreement BIONTECH
View entire presentation